BOSTON SCIENTIFIC CORPORATION Operating Lease, Payments
BOSTON SCIENTIFIC CORPORATION (BSX) reported Operating Lease, Payments of $111.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-17.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2026-02-17
- BOSTON SCIENTIFIC CORPORATION operating lease, payments for the quarter ending 2019-12-31 was $22.00M.
- BOSTON SCIENTIFIC CORPORATION operating lease, payments for the quarter ending 2019-09-30 was $20.00M.
- BOSTON SCIENTIFIC CORPORATION operating lease, payments for the quarter ending 2019-06-30 was $18.00M.
- BOSTON SCIENTIFIC CORPORATION operating lease, payments for the quarter ending 2019-03-31 was $17.00M.
- BOSTON SCIENTIFIC CORPORATION operating lease, payments for fiscal 2025 was $111.00M, a 14.43% increase from fiscal 2024.
- BOSTON SCIENTIFIC CORPORATION operating lease, payments for fiscal 2024 was $97.00M, a 4.30% increase from fiscal 2023.
- BOSTON SCIENTIFIC CORPORATION operating lease, payments for fiscal 2023 was $93.00M, a 2.20% increase from fiscal 2022.
- BOSTON SCIENTIFIC CORPORATION operating lease, payments for fiscal 2022 was $91.00M, a 4.60% increase from fiscal 2021.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month |
|---|---|---|---|---|
| 2025-12-31 | $111.00M 10-K · filed 2026-02-17 | |||
| 2024-12-31 | $97.00M 10-K · filed 2026-02-17 | |||
| 2023-12-31 | $93.00M 10-K · filed 2026-02-17 | |||
| 2022-12-31 | $91.00M 10-K · filed 2024-02-20 | |||
| 2021-12-31 | $87.00M 10-K · filed 2023-02-23 | |||
| 2020-12-31 | $91.00M 10-K · filed 2022-02-23 | |||
| 2019-12-31 | $22.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $42.00M derived: sum of 2 quarters · filed 2021-02-23 | $60.00M derived: sum of 3 quarters · filed 2021-02-23 | $77.00M 10-K · filed 2021-02-23 |
| 2019-09-30 | $20.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $38.00M derived: sum of 2 quarters · filed 2019-11-05 | $55.00M 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $18.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-30 | $35.00M 10-Q · filed 2019-07-30 | ||
| 2019-03-31 | $17.00M 10-Q · filed 2019-04-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |